Tarsus Pharmaceuticals, Inc. TARS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.99B.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s market capitalization?
- Tarsus Pharmaceuticals, Inc. (TARS) reported market capitalization of $2.99B in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s market capitalization increased by 41.1% year-over-year, from $2.12B to $2.99B.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s market capitalization has grown at a 32.8% compound annual growth rate (CAGR), from $840.49M to $3.48B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.